Crommentuijn et al. [117] described the presence of a tumor antigen-specific CD8+ T cell population which displays a tolerogenic phenotype with a high expression of several immune checkpoints such as PD-1 and T cell immunoglobulin and ITIM domain (TIGIT). The gene discussed is CD8A; the disease is neoplasm.